➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Express Scripts
Colorcon
Moodys
Dow

Last Updated: October 20, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 212024

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 212024 describes LEVORPHANOL TARTRATE, which is a drug marketed by Novitium Pharma, Sentynl Theraps Inc, Specgx Llc, and Virtus Pharms, and is included in four NDAs. It is available from four suppliers. Additional details are available on the LEVORPHANOL TARTRATE profile page.

The generic ingredient in LEVORPHANOL TARTRATE is levorphanol tartrate. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the levorphanol tartrate profile page.
Summary for 212024
Tradename:LEVORPHANOL TARTRATE
Applicant:Specgx Llc
Ingredient:levorphanol tartrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 212024
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for 212024
Suppliers and Packaging for NDA: 212024
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LEVORPHANOL TARTRATE levorphanol tartrate TABLET;ORAL 212024 ANDA SpecGx LLC 0406-2224 0406-2224-01 100 TABLET in 1 BOTTLE, PLASTIC (0406-2224-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Dec 13, 2019TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Boehringer Ingelheim
Harvard Business School
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.